HURA
TuHURA Biosciences Inc
NASDAQ: HURA · HEALTHCARE · BIOTECHNOLOGY
$2.10
-1.41% today
Updated 2026-04-29
Market cap
$141.14M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.63
Dividend yield
—
52W range
$0 – $4
Volume
1.1M
TuHURA Biosciences Inc (HURA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-169.20%
ROA
-74.30%
Debt/equity
0.03x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2010 | — | $-5582.00 | — | — | — |
| 2011 | — | $-33136.00 | — | — | — |
| 2012 | — | $-18885.00 | — | — | — |
| 2014 | — | $-8.29M | — | — | — |
| 2015 | — | $-4.35M | — | — | — |
| 2016 | — | $-8.86M | — | — | — |
| 2017 | — | $-8.08M | — | — | — |
| 2018 | — | $-11.14M | — | — | — |
| 2019 | — | $-8.05M | — | — | — |
| 2020 | — | $-9.13M | — | — | — |
| 2021 | — | $-38.30M | — | — | — |
| 2022 | $0.00 | $-22.66M | — | — | — |
| 2023 | $0.00 | $-14.65M | — | — | — |
| 2024 | $0.00 | $-8.32M | — | — | — |
| 2025 | $0.00 | $-21.68M | — | — | — |